Prostate Cancer Clinical Trials Consortium
Clinical trials sponsored by Prostate Cancer Clinical Trials Consortium, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- DNA registry aims to decode how inherited genes shape prostate cancer Results expected Dec 2026 (estimated)
-
New hope for tough prostate cancer: drug combo aims to delay progression
Disease control Recruiting nowThis study tests whether the drug talazoparib, given alone or with enzalutamide, can slow down cancer growth in men with a certain type of advanced prostate cancer that has stopped responding to a previous treatment called abiraterone. About 126 participants with specific gene ch…
Phase 2 • Sponsor: Prostate Cancer Clinical Trials Consortium • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
DNA registry aims to decode how inherited genes shape prostate cancer
Knowledge-focused Recruiting nowThe PROMISE registry collects health information and saliva samples from people diagnosed with prostate cancer at any stage. Researchers test the samples for inherited gene variants that raise cancer risk and follow participants for at least 15 years. The goal is to learn how the…
Sponsor: Prostate Cancer Clinical Trials Consortium • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Massive global registry launches to track prostate cancer care worldwide
Knowledge-focused Recruiting nowThis study is a large international registry that will follow at least 5,000 men with advanced prostate cancer for five years or more. Researchers will collect detailed information on treatments, side effects, and quality of life to see which approaches work best. The goal is to …
Sponsor: Prostate Cancer Clinical Trials Consortium • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC